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A 28-year-old man was admitted to our hospital because of reduced livido and increased fatigability. Four months before
admission,henoticedpolyuria,whichwasgraduallyrelievedbyadmission.Magneticresonanceimagingrevealedenhancinglesion
centrallyinthepituitarystalk.Biopsyfromtheskinrevealednoncaseatinggranulomacomposedofepithelioidcells,andadiagnosis
of sarcoidosis was made. Although plasma arginine vasopressin (AVP) was undetectable after administration of hypertonic saline,
urinaryoutputwaswithinnormalrange(1.5to2.2L/day).Theurineosmolalitybecameaboveplasmalevelsduringthehypertonic
saline test. Hormonal provocative tests revealed partial glucocorticoid deﬁciency. Soon after the glucocorticoid therapy was begun,
moderate polyuria (from 3.5–4.0liters daily) occurred. At this time, plasma AVP was undetectable, and urine osmolality was
consistently below plasma levels during the hypertonic saline test. In conclusion, we showed in human study that masked diabetes
insipidus could be mediated by AVP-independent mechanisms.
1.Introduction
It is well recognized that polyuria is relieved in patients with
central diabetes insipidus (CDI), when they also experience
glucocorticoid (GC) deﬁciency; this phenomenon is known
asmaskeddiabetesinsipidus(DI).However,themechanisms
mediating masked DI are not clear. GC deﬁciency is known
to increase levels of arginine vasopressin (AVP) [1]a n d
exaggerate the action of AVP [2], suggesting that masked
DI is mediated mainly by AVP-dependent mechanisms. On
the other hand, in animal models of DI (Brattleboro rats;
hereditary hypothalamic AVP-deﬁcient rats), GC deﬁciency
caused impaired water excretion [3], suggesting that AVP-
independent mechanisms are also involved. To elucidate the
role of AVP in masked DI, it is essential to evaluate plasma
AVP levels using a hypertonic saline infusion test before
and after GC replacement. However, such cases are seldom
reported [4], most likely becauseclinicians do not suspectDI
duringnonpolyuricperiods.Thus,theroleofAVPinmasked
DI is still controversial.
Here, we report a patient with sarcoidosis complicated
by CDI and GC deﬁciency in whom a hypertonic saline
infusion test was done before and after GC replacement.
Results showed that masked DI could be mediated solely by
AVP-independent mechanisms.
2.CaseReport
A 28-year-old man was admitted to our hospital because
of reduced livido and increased fatigability. He had been in
good health until 1 year earlier, when he noticed reduced2 Case Reports in Medicine
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Figure 1: Photograph of the skin of the forehead (a) and pathological ﬁnding of the skin biopsy (b). Noncaseating granuloma composed of
epithelioid cells and multinucleated giant cells were present.
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Figure 2: Hypertonic saline test before (a) and after (b) glucocorticoid therapy. Before therapy, although plasma AVP was undetectable,
urine became concentrated. After therapy, the hypertonic saline test failed to concentrate the urine and AVP was undetectable.
livido. Four months before admission, he noticed frequent
headaches, thirst, polydipsia, and polyuria. Because he was
voiding urine every hour, he visited his family doctor.
Magnetic resonance imaging (MRI) revealed a suprasellar
mass, and he was thus referred to our hospital for further
evaluation and treatment. Although polydipsia and polyuria
had been gradually relieved by the time of admission, he
became aware of increased fatigability.
At the time of admission, he was 176cm tall and
weighed 72kg. His temperature was 37.6◦C, pulse rate was
60/min, and blood pressure was 110/60mmHg. No goiter or
enlargement of lymph nodes was noted. Axillar and pubic
hair were lost and there was palpable erythematous rush on
his forehead (Figure 1(a)). The remainder of the physical
examination was unremarkable.
Laboratory results revealed the following results: blood
urea nitrogen 9.6mg/dL, creatinine 0.79mg/dL, serum
sodium141mEq/l,potassium4.0mEq/l,chloride100mEq/l,
calcium 9.4mg/dL, phosphate 3.7mg/dL, fasting plasma
glucose 80mg/dL, and C-reactive protein 0.07mg/dL.
Endocrinologic data revealed a mild decrease in free T4
level (0.6ng/dL) with normal thyroid-stimulating hor-
mone (TSH) level (0.9106μU/mL) and decreased cor-
tisol (4.7μg/mL), adrenocorticotropic hormone (ACTH;
6pg/mL), luteinizing hormone (LH; 0.2mIU/mL), follicle
stimulating hormone (FSH; 1.3mIU/mL), and testosterone
(0.05ng/mL) levels. Urinary cortisol was undetectable.
Plasma osmolality was 288mOsm/kgH2O, with a urinary
osmolality of 239mOsm/kgH2O, and arginine vasopressin
(AVP) was undetectable (<0.15pg/mL). Urinary output was
f r o m1 . 5t o2 . 2L / d a y .
His clinical course and laboratory ﬁndings led us to
suspect CDI with anterior pituitary dysfunction. We thus
performed hormonal provocative tests. The patient was
given an infusion of 5% saline at a rate of 0.05mL/kg for
120min. Although plasma AVP was undetectable before and
after administration of hypertonic saline, urine osmolal-
ity (391mOsm/kgH2O) increased above the plasma levels
(296mOsm/kgH2O) (Figure 2(a)). Hormonal provocative
tests revealed that growth hormone (GH) response to GH-
releasing hormone was normal, TSH response to TSH-
releasing hormone was low and blunted, and FSH and LHCase Reports in Medicine 3
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Figure 3: Hormonal provocative test results.
(a) (b)
Figure 4: T1-weighted MRI of the sella turnica after administration of gadolinium revealed enhancing lesion centrally in the pituitary stalk,
which spread continuously to the bottom of the third ventricle, and high intensity of posterior lobe was lost.
response to LH-releasing hormone were low and blunted
(Figure 3). Although ACTH response to corticotrophin-
releasing hormone (CRH) was normal, cortisol response to
CRH was low (maximum 13.0μg/mL). Cortisol response
to rapid ACTH stimulation test was low (maximum
15.9μg/mL).Resultsofthesehormonaltestswerecompatible
with the diagnosis of CDI with partial GC deﬁciency.
MRI revealed enhancing lesion centrally in the pituitary
stalk, which spread continuously to the bottom of the
third ventricle, and the high intensity of the posterior lobe
was lost, compatible with the diagnosis of CDI (Figure 4).
Considering the patient’s age, we ﬁrst suspected of neuro-
hypophysial germinoma. However, this was unlikely because
cerebrospinal ﬂuid was negative for malignant cells, and β-
human chorionic gonadotropin (HCG) levels were normal.
Next, we suspected sarcoidosis because chest X-ray revealed
hilar enlargement. A biopsy from the skin of the forehead
was performed, which revealed noncaseating granuloma4 Case Reports in Medicine
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Hypertonic saline test DDAVP: 1-desamino-8-D-arginine vasopressin
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Figure 5: Clinical course.
composed of epithelioid cells (Figure 1(b)). Multinucleated
giant cells were also present. Thus, the diagnosis of sarcoido-
sis was made.
While waiting for histologic conﬁrmation of biopsy
results, hydrocortisone replacement was begun with a dose
of 20mg daily. Soon after the replacement therapy was
begun, moderate polyuria (3.5–4.0 liters daily) occurred
(Figure 2(b)). After the diagnosis of sarcoidosis was con-
ﬁrmed, he was treated with 40mg of prednisolone and his
general condition improved. The hypertonic saline test was
repeated while he was taking 40mg of prednisolone. Plasma
AVP was undetectable during the hypertonic saline test
and urine osmolality was consistently below plasma levels,
which was compatible with a diagnosis of CDI (Figure 5).
He was treated with 1-desamino-8-D-arginine vasopressin
(dDAVP).
MRIfollowingprednisolonetherapyrevealedareduction
in the size of the aﬀected lesion. However, his pituitary
function remained unchanged, and he is currently being
treatedwithprednisolone,levothyroxinenatrium,HCG,and
dDAVP.
3. Discussion
It is diﬃcult to suspect the existence of “masked DI”
before starting GC replacement therapy because patients
do not complain of characteristic symptoms of DI such as
polyuria and polydipsia. The present patient’s symptoms of
polyuriaandpolydipsiagraduallydecreasedwhilefatigability
gradually increased, which prompted us to suspect the
likelihood of masked DI. We thus performed the hypertonic
saline test even though he did not complain of overt polyuria
onadmission.AlthoughplasmaAVPwasundetectablebefore
and after administration of hypertonic saline, urine osmo-
lality increased above plasma levels. Radioimmunoassay
for AVP is sensitive enough to detect a small quantity of
circulating AVP, suggesting that kidneys can concentrate
the urine even if circulating AVP is completely deﬁcient.
AfterstartingGCreplacement,plasmaAVPwasundetectable
before and after administration of hypertonic saline. How-
ever, urine osmolality was consistently below plasma levels.
These observations suggest that GC deﬁciency can cause
impaired water excretion, which is not mediated by AVP-
dependent mechanisms.
Although AVP-deﬁcient rat models clearly show that GC
deﬁciency can cause impaired water excretion independent
of AVP, the underlying mechanisms are still unclear. In
one study, adrenalectomized Brattleboro rats experienced a
rise in water permeability of the distal tubules, suggesting
that one of the mechanisms might be direct action of GC
on renal tubules [5]. On the other hand, GC dilates both
aﬀerent and eﬀerent resistances and results in an increase
in glomerular ﬁltration rate (GFR), by which GC increases
the rate of water ﬂow into the nephron [6]. Thus, GC-
induced increase in water excretion may be secondary to an
elevation in GFR. GC has been reported to directly stimulate
the production of atrial natriuretic polypeptide (ANP) [7]
and potentiate the action of ANP [8], resulting in increaseCase Reports in Medicine 5
in GFR. Furthermore, GC deﬁciency was associated with a
signiﬁcantly lower cardiac index [9]. Therefore, GC-induced
increase in water excretion may be secondary to changes in
systemic and renal hemodynamics as well as direct actions
on the tubules. Unfortunately, these hemodynamic studies
were not done in the present case, although systemic blood
pressure and serum creatinine levels were unchanged. Thus,
the AVP-independent mechanisms by which GC deﬁciency
caused impaired water excretion in the present case are
unknown.
After starting GC therapy, the diagnosis of CDI became
certain based on the results of the hypertonic saline infusion
test. However, the degree of polyuria (3.5–4L/d) was moder-
ate, and maximum urine osmolality was not extremely low
(259mOsm/kgH2O) despite undetectable AVP. However, we
performed the hypertonic saline test soon after starting GC
therapy and it is possible that it takes more time until GC
completely restores the diluting ability of urine. Not only
GC deﬁciency but also mineralcorticoid (MC) deﬁciency is
involvedintheimpairedwaterexcretioninadrenalectomized
Brattleboro rats. Thus, MC deﬁciency could be one reason
that the degree of polyuria was moderate even after the GC
replacement. We did not check the aldosterone level in this
study because secretion of aldosterone is usually preserved in
patients with central adrenal deﬁciency.
Sarcoidosis is a systemic disorder of unknown cause that
is characterized pathologically by noncaseating granuloma.
Although involvement of sarcoidosis in the central nervous
system is rare (approximately 5%), the hypothalamus is one
of the most aﬀected organs in neurosarcoidosis. Thus, vari-
ous degrees of secondary hypopituitarism can occur. Among
them, CDI is the most reported endocrine abnormality,
occurring in 25% of patients with neurosarcoidosis [10].
Although any degree of anterior pituitary insuﬃciency can
also occur, gonadotropin deﬁciency is most common. In the
present case, endocrinologic manifestations (hypogonadism
and DI) were the ﬁrst clinical symptoms of sarcoidosis.
Five similar cases have been reported, in which CDI
and hypogonadism were the ﬁrst clinical presentations of
neurosarcoidosis [11]. Thus, endocrinologic manifestations
could be the ﬁrst clinical presentations of neurosarcoidosis.
It has been reported that 97% of patients with neurosar-
coidosis have systemic involvement of sarcoidosis even if
they are asymptomatic [12]. Furthermore, considering that
other hypothalamic lesions causing CDI such as Wegener’s
granulomatosis [13] and IgG4-related sclerosing disease [14]
usually have extra-hypothalamic lesions, clinicians should
search for systemic involvement to establish the diagnosis
if patients are otherwise asymptomatic. In the present case,
careful observation of the skin prompted us to obtain a
biopsy specimen, which led to proper diagnosis.
In summary, we report on a patient with sarcoidosis
complicated by CDI and GC deﬁciency, whose urine became
concentrated after the administration of hypertonic saline
although AVP was undetectable. However, following GC
therapy, hypertonic saline failed to concentrate the urine. In
conclusion, we showed in human study that masked diabetes
insipidus could be mediated solely by AVP-independent
mechanisms.
References
[1] H.Raﬀ,“Glucocorticoid inhibitionofneurohypophysial vaso-
pressinsecretion,”AmericanJournalofPhysiology,vol.252,no.
4, pp. R635–R644, 1987.
[2] S. Ishikawa and R. W. Schrier, “Eﬀect of arginine vasopressin
antagonist on renal water excretion in glucocorticoid and
mineralocorticoiddeﬁcientrats,”KidneyInternational,vol.22,
no. 6, pp. 587–593, 1982.
[ 3 ]H .H .G r e e n ,A .R .H a r r i n g t o n ,a n dH .V a l t i n ,“ O nt h er o l e
of antidiuretic hormone in the inhibition of acute water
diuresis in adrenal insuﬃciency and the eﬀects of gluco-
and mineralocorticoids in reversing the inhibition,” Journal of
Clinical Investigation, vol. 49, no. 9, pp. 1724–1736, 1970.
[ 4 ]Y .I w a s a k i ,K .K o n d o ,H .H a s e g a w ae ta l . ,“ O s m o r e g u l a t i o no f
plasma vasopressin in three cases with adrenal insuﬃciency of
diverseetiologies,”HormoneResearch,vol.47,no.1,pp.38–44,
1997.
[5] D. J. Hirsch and R. W. Hirtle, “Eﬀect of adrenalectomy
on distal tubule water permeability of the Brattleboro rat,”
Canadian Journal of Physiology and Pharmacology, vol. 64, no.
9, pp. 1170–1176, 1986.
[6] C. Baylis, R. K. Handa, and M. Sorkin, “Glucocorticoids and
control of glomerular ﬁltration rate,” Seminars in Nephrology,
vol. 10, no. 4, pp. 320–329, 1990.
[7] D.G.Gardner,S.Hane,D.Trachewskyetal.,“Atrialnatriuretic
peptide mRNA is regulated by glucocorticoids in vivo,”
Biochemical and Biophysical Research Communications, vol.
139, no. 3, pp. 1047–1054, 1986.
[8] S. Hayamizu, K. Kanda, S. Ohmori, Y. Murata, and H. Seo,
“Glucocorticoids potentiate the action of atrial natriuretic
polypeptide in adrenalectomized rats,” Endocrinology, vol.
135, no. 6, pp. 2459–2464, 1994.
[9] S. L. Linas, T. Berl, and G. L. Robertson, “Role of vasopressin
in the impaired water excretion of glucocorticoid deﬁciency,”
Kidney International, vol. 18, no. 1, pp. 58–67, 1980.
[10] V. Oksanen, “Neurosarcoidosis: clinical presentations and
course in 50 patients,” Acta Neurologica Scandinavica, vol. 73,
no. 3, pp. 283–290, 1986.
[11] C. Bullmann, M. Faust, A. Hoﬀmann et al., “Five cases with
central diabetes insipidus and hypogonadism as ﬁrst presenta-
tion of neurosarcoidosis,” European Journal of Endocrinology,
vol. 142, no. 4, pp. 365–372, 2000.
[12] B. J. Stern, A. Krumholz, C. Johns et al., “Sarcoidosis and its
neurological manifestations,” Archives of Neurology, vol. 42,
no. 9, pp. 909–917, 1985.
[13] N. D¨ uzg¨ un, Y. Morris, S. G¨ ull¨ u et al., “Diabetes insipidus
presentation before renal and pulmonary features in a patient
with Wegener’s granulomatosis,” Rheumatology International,
vol. 26, no. 1, pp. 80–82, 2005.
[14] Y. Isaka, K. Yoshioka, M. Nishio et al., “A case of IgG4-
related multifocal ﬁbrosclerosis complicated by central dia-
betes insipidus,” Endocrine Journal, vol. 55, no. 4, pp. 723–728,
2008.